4.27Nuclear cardiological effects of selective angiotensin receptor antagonist, termisaltan to hypertrophic cardiomyopathy -improvement of myocardial perfusion and fatty acid metabolism

Authors :: Y WATANABE
R YAMAUCHI
H HIGUCHI
A YUKAWA
A SUZUKI
K TANAKA
N EJIRI
Source :: Journal of Nuclear Cardiology. 14:S27-S27
Publication Year :: 2007
Publisher :: Springer Science and Business Media LLC, 2007.

Subjects :: medicine.medical_specialty
Fatty acid metabolism
business.industry
Hypertrophic cardiomyopathy
medicine.disease
chemistry.chemical_compound
Endocrinology
chemistry
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
Angiotensin receptor antagonist
Cardiology and Cardiovascular Medicine
business
Perfusion

Full Text Access

Tools